TGA Approval

DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial (379590)

ARTG ID

379590

ARTG Name

DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial

Sponsor

Fresenius Kabi Australia Pty Ltd

ARTG Date

November 23, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Fresenius Kabi Australia Pty Ltd.

Ingredient Name

dexmedetomidine hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.

DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial (379590) - TGA 批准文号 | MedPath